Friday, November 6, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

Palantir Shares Face Steep Decline Amid Valuation Concerns

Robert Sasse by Robert Sasse
November 29, 2025
in AI & Quantum Computing, Analysis, Nasdaq, Tech & Software
0
Palantir Stock
0
SHARES
86
VIEWS
Share on FacebookShare on Twitter

The investment landscape for Palantir Technologies Inc. shifted dramatically in November, as the data analytics firm experienced its most severe monthly decline in over two years. Previously regarded as an unstoppable force in the artificial intelligence sector, the company now finds itself at the center of a heated debate between its chief executive and a prominent hedge fund manager, leaving investors to question whether this represents a buying opportunity or the end of an era.

Strong Fundamentals Clash With Market Sentiment

Paradoxically, Palantir’s operational performance remains robust. The company’s latest quarterly report significantly exceeded Wall Street’s expectations across multiple metrics:
* Revenue surged by 63 percent year-over-year
* Commercial revenue in the United States exploded by 121 percent
* Adjusted earnings per share doubled compared to previous periods

Despite these strong results and an upward revision to annual forecasts, including major contract wins with organizations like PwC UK, investor confidence has been undermined by concerns over the company’s valuation. The situation was further complicated by insider selling activity, with CEO Alex Karp and other executives divesting portions of their holdings during November.

Sector-Wide Rotation Hits AI Stocks

The downturn reflects broader market dynamics rather than company-specific issues alone. November witnessed a significant sector rotation as investors retreated from highly-valued AI securities. Even industry heavyweights including Nvidia and Microsoft saw their share prices retreat during this period.

Market analysts have expressed growing apprehension about valuation levels. Researchers at Jefferies have characterized current pricing as “extreme,” while Deutsche Bank has voiced skepticism about how such astronomical metrics can be justified. With a price-to-earnings ratio that exceeds conventional investment parameters and a Relative Strength Index approaching 79—indicating severely overbought conditions—the risk profile has increased substantially.

Should investors sell immediately? Or is it worth buying Palantir?

High-Profile Clash Highlights Diverging Views

Amid this turbulent backdrop, a public dispute has emerged between Palantir’s leadership and notable investor Michael Burry. The fund manager, who gained fame for his successful bet against the housing market in 2008, has established substantial put options against Palantir with a notional value approaching $1 billion as disclosed in late September.

The response from Palantir’s executive suite was immediate and forceful. Chief Executive Officer Alex Karp used two separate television appearances within a single week to denounce Burry’s position as “completely insane” and implicitly accused him of market manipulation. Burry countered in his latest investment newsletter, arguing that markets have fundamentally misjudged both the lifespan of AI chips and the depreciation cycles affecting major technology firms—a direct challenge to the foundation of the current AI investment boom.

Market Performance and Outlook

Palantir shares concluded recent trading at 145.54 euros, reflecting a decline exceeding 15 percent over a 30-day window. Despite this pullback, the equity maintains a substantial gain of nearly 99 percent since the beginning of the year.

The investment community remains deeply divided. On one side stand impressive operational growth figures and expanding business opportunities. On the other, stretched valuations that permit no margin for error and influential short sellers betting on a substantial correction. Market participants should prepare for continued volatility until the tension between fundamental valuation concerns and AI-driven optimism reaches resolution.

Ad

Palantir Stock: Buy or Sell?! New Palantir Analysis from November 5 delivers the answer:

The latest Palantir figures speak for themselves: Urgent action needed for Palantir investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 5.

Palantir: Buy or sell? Read more here...

Tags: Palantir
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Micron Technology Stock
AI & Quantum Computing

Micron’s Rally Faces Its Moment of Reckoning: A Downgrade, a Labor Standoff, and a Date With the Numbers

September 9, 2026
SAP Stock
Analysis

SAP’s Buyback Machine Grinds On, But the Analyst Chorus Is Turning Sour

September 7, 2026
Münchener Rück Stock
Analysis

Munich Re’s Monte Carlo Warning Collides With Wall Street’s Widest Analyst Split in Years

September 7, 2026
Next Post
Redcare Pharmacy Stock

Redcare Pharmacy Shares Show Signs of Recovery After Steep Decline

Silber Preis Stock

Silver Soars to Unprecedented Heights as Supply Squeeze Intensifies

Figma Stock

Figma Shares Navigate Critical Juncture After Steep Decline

Recommended

indiemiconductor Stock

Indie Semiconductor Shares Face Technical Headwinds

1 year ago
BioNTech Stock

BioNTech Secures CureVac Acquisition in Landmark mRNA Deal

11 months ago
Food Retailers Market Capitalization

Victorias Secret Reports Strong Earnings Growth and Strategic Initiatives for Future Success

3 years ago

CNH Industrials Financial Report for Q4 2023 Meeting Expectations and Predicting a Slowdown in 2024

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum DroneShield Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Profits Show Up Beyond AI, Even When Deal Premiums Don’t

Pharma Pays for the Rotation While Crypto Hunts for a Floor

Tech Loses $1 Trillion, but the Rest of the Market Holds

Alphabet’s Cloud Doubles, Its Cash Turns Negative, the Stock Sinks

Margins Over Stories: Who Delivers Before the Fed and Big Tech

UPS and Coca-Cola Raise Guidance by Charging More, Not Selling More

Trending

Fastly Stock
Newsletter

Maersk Lifts Guidance a Third Time, and the Stock Still Sinks

by Stephanie Dugan
November 5, 2026
0

Dear readers, Raised guidance was supposed to be the safe harbor of earnings season. Maersk has tested...

AMD Stock

Democrats Win, and the Market Sorts Solar From Musk and Defense

November 4, 2026
Apple Stock

Good Quarters, Heavy Selling: Cash Flow Beats Growth on Election Day

November 3, 2026
Lumentum Stock

Profits Show Up Beyond AI, Even When Deal Premiums Don’t

November 2, 2026
Bitcoin Stock

Pharma Pays for the Rotation While Crypto Hunts for a Floor

October 31, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Maersk Lifts Guidance a Third Time, and the Stock Still Sinks
  • Democrats Win, and the Market Sorts Solar From Musk and Defense
  • Good Quarters, Heavy Selling: Cash Flow Beats Growth on Election Day

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com